When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yuying Chen, Li Ding, Shan Zhao, Weihong Wang, Jing Zhong, Qiang Yan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Published: (2026)
Published: (2026)
Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐Analysis
by: Lei Liu, et al.
Published: (2025)
by: Lei Liu, et al.
Published: (2025)
The Role of Magnesium in Liver Cirrhosis
by: Weiye Zeng, et al.
Published: (2025)
by: Weiye Zeng, et al.
Published: (2025)
Liver Cirrhosis and Sleep Disorders
by: Jiawen Feng, et al.
Published: (2025)
by: Jiawen Feng, et al.
Published: (2025)
Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
by: Rong Wang, et al.
Published: (2026)
by: Rong Wang, et al.
Published: (2026)
Artificial Liver Therapy Ameliorates Hepatitis B Virus–Related Acute‐on‐Chronic Liver Failure by Remodeling the Microbiota Structure
by: Wei Huang, et al.
Published: (2025)
by: Wei Huang, et al.
Published: (2025)
LiverRCT IIT : Promoting Investigator‐Initiated Randomized Controlled Trials for the Key Clinical Issues in Liver Disease Prevention and Treatment
by: Xiaolong Qi, et al.
Published: (2025)
by: Xiaolong Qi, et al.
Published: (2025)
The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
by: Jiamin Xu, et al.
Published: (2026)
by: Jiamin Xu, et al.
Published: (2026)
Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
by: Chang‐Hai Liu, et al.
Published: (2025)
by: Chang‐Hai Liu, et al.
Published: (2025)
Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD
by: Parinda Prathyajuta, et al.
Published: (2026)
by: Parinda Prathyajuta, et al.
Published: (2026)
Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1
by: Lixia Sun, et al.
Published: (2026)
by: Lixia Sun, et al.
Published: (2026)
Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma Located at Esophageal Varices Caused by Liver Cirrhosis
by: Wenlan Zheng, et al.
Published: (2025)
by: Wenlan Zheng, et al.
Published: (2025)
Sono‐Vasomics With Super‐Resolution Contrast‐Enhanced Ultrasound (SR‐CEUS) for Characterization of Focal Liver Lesions: A Case Report
by: Yijie Qiu, et al.
Published: (2026)
by: Yijie Qiu, et al.
Published: (2026)
Correction to “Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1”
Published: (2026)
Published: (2026)
Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021
by: Jiaqi Ruan, et al.
Published: (2026)
by: Jiaqi Ruan, et al.
Published: (2026)
Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
by: Lindan Xie, et al.
Published: (2025)
by: Lindan Xie, et al.
Published: (2025)
Comparable Diagnostic Accuracy but Discordant Thresholds Between FibroTouch and FibroScan: A Biopsy‐Based Comparative Study
by: Min Wang, et al.
Published: (2026)
by: Min Wang, et al.
Published: (2026)
Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
by: Yi‐Han Yang, et al.
Published: (2025)
by: Yi‐Han Yang, et al.
Published: (2025)
Research Progress of Noninvasive Evaluation of Portal Hypertension by Blood‐Based Tests
by: Wei Chen, et al.
Published: (2025)
by: Wei Chen, et al.
Published: (2025)
Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave Elastography
by: Lan Wang, et al.
Published: (2025)
by: Lan Wang, et al.
Published: (2025)
Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy
by: Jun Tie, et al.
Published: (2026)
by: Jun Tie, et al.
Published: (2026)
One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
by: Jitao Wang, et al.
Published: (2024)
by: Jitao Wang, et al.
Published: (2024)
Endovascular embolization for upper gastrointestinal bleeding due to portal hypertension caused by a superior mesenteric arteriovenous fistula
by: Yu He, et al.
Published: (2024)
by: Yu He, et al.
Published: (2024)
Treatment strategy for erythropoietic protoporphyria accompanied by severe abdominal pain and liver injury
by: Xiaoxin Wu, et al.
Published: (2024)
by: Xiaoxin Wu, et al.
Published: (2024)
Appraising the causal effects of circulating micronutrients on liver cirrhosis: Evidence from large‐scale Mendelian randomization analysis
by: Junlong Lin, et al.
Published: (2024)
by: Junlong Lin, et al.
Published: (2024)
The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory Cirrhosis
by: Qiran Zhang, et al.
Published: (2026)
by: Qiran Zhang, et al.
Published: (2026)
Application of graph theory in liver research: A review
by: Xumei Hu, et al.
Published: (2024)
by: Xumei Hu, et al.
Published: (2024)
Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis
by: Siyu Jiang, et al.
Published: (2025)
by: Siyu Jiang, et al.
Published: (2025)
Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study
by: Yi Xiang, et al.
Published: (2026)
by: Yi Xiang, et al.
Published: (2026)
Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
by: Jiachi Yu, et al.
Published: (2024)
by: Jiachi Yu, et al.
Published: (2024)
Successful Embolization for Recurrent Encephalopathy Caused by Type II Abernethy Malformation
by: Hongliang Wang, et al.
Published: (2025)
by: Hongliang Wang, et al.
Published: (2025)
Exploring the predictive value of serum lipids for short‐term prognosis in patients with acute‐on‐chronic liver failure
by: Yunfeng Fu, et al.
Published: (2024)
by: Yunfeng Fu, et al.
Published: (2024)
Capsule endoscopy in portal hypertension and varices
by: Jun Pan, et al.
Published: (2024)
by: Jun Pan, et al.
Published: (2024)
Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023
by: Jiaming Lan, et al.
Published: (2024)
by: Jiaming Lan, et al.
Published: (2024)
Global status and trends in hepatitis B virus DNA mutation research from 2003 to 2022: A comprehensive bibliometric view
by: Ming Li, et al.
Published: (2024)
by: Ming Li, et al.
Published: (2024)
Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective study
by: Tongqiang Li, et al.
Published: (2024)
by: Tongqiang Li, et al.
Published: (2024)
Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in Cirrhosis
by: Danping Huang, et al.
Published: (2026)
by: Danping Huang, et al.
Published: (2026)
Application of subharmonic‐aided pressure estimation in a patient with giant hepatic cyst: A case report
by: Xiuyun Lu, et al.
Published: (2024)
by: Xiuyun Lu, et al.
Published: (2024)
Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
by: Qiaofeng Chen, et al.
Published: (2025)
by: Qiaofeng Chen, et al.
Published: (2025)
The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALD
by: Yee Hui Yeo, et al.
Published: (2025)
by: Yee Hui Yeo, et al.
Published: (2025)
Similar Items
-
Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Published: (2026) -
Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐Analysis
by: Lei Liu, et al.
Published: (2025) -
The Role of Magnesium in Liver Cirrhosis
by: Weiye Zeng, et al.
Published: (2025) -
Liver Cirrhosis and Sleep Disorders
by: Jiawen Feng, et al.
Published: (2025) -
Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
by: Rong Wang, et al.
Published: (2026)